Interactions of the platelets in paroxysmal nocturnal hemoglobinuria with complement. Relationship to defects in the regulation of complement and to platelet survival in vivo
- PMID: 2432087
- PMCID: PMC424006
- DOI: 10.1172/JCI112773
Interactions of the platelets in paroxysmal nocturnal hemoglobinuria with complement. Relationship to defects in the regulation of complement and to platelet survival in vivo
Abstract
The blood cells of patients with paroxysmal nocturnal hemoglobinuria (PNH) have abnormal interactions with complement. The activity of the alternative pathway C3 convertase on the platelets of 9 out of 19 patients with PNH was elevated. 10 patients had C3 convertase activity within the normal range even though 80-95% of their platelets lacked the complement regulatory protein decay accelerating factor (DAF) that is absent from the affected blood cells in PNH. PNH and normal platelets released factor H when C3 was bound to their surfaces. This may account for the apparent regulation of C3 convertase activity on platelets that lack DAF. The abnormal uptake of the membrane attack complex of complement by PNH III erythrocytes was not seen in PNH platelets. 111Indium-labeled platelet survival times were normal in five of eight patients, which suggests that the lack of the membrane attack complex defect results in normal platelet survival in PNH.
Similar articles
-
Paroxysmal nocturnal hemoglobinuria: deficiency in factor H-like functions of the abnormal erythrocytes.J Exp Med. 1983 Jun 1;157(6):1971-80. doi: 10.1084/jem.157.6.1971. J Exp Med. 1983. PMID: 6222136 Free PMC article.
-
Affected erythrocytes of patients with paroxysmal nocturnal hemoglobinuria are deficient in the complement regulatory protein, decay accelerating factor.Proc Natl Acad Sci U S A. 1983 Aug;80(16):5066-70. doi: 10.1073/pnas.80.16.5066. Proc Natl Acad Sci U S A. 1983. PMID: 6576376 Free PMC article.
-
Molecular basis of the enhanced susceptibility of the erythrocytes of paroxysmal nocturnal hemoglobinuria to hemolysis in acidified serum.Blood. 1991 Aug 1;78(3):820-9. Blood. 1991. PMID: 1713516
-
Distribution of decay-accelerating factor in the peripheral blood of normal individuals and patients with paroxysmal nocturnal hemoglobinuria.J Exp Med. 1985 Jul 1;162(1):75-92. doi: 10.1084/jem.162.1.75. J Exp Med. 1985. PMID: 2409211 Free PMC article. Review.
-
Erythrocyte membrane protein deficiencies in paroxysmal nocturnal hemoglobinuria.Am J Med. 1989 Sep;87(3N):22N-29N. Am J Med. 1989. PMID: 2484793 Review.
Cited by
-
Identification of a novel mode of complement activation on stimulated platelets mediated by properdin and C3(H2O).J Immunol. 2013 Jun 15;190(12):6457-67. doi: 10.4049/jimmunol.1300610. Epub 2013 May 15. J Immunol. 2013. PMID: 23677468 Free PMC article.
-
Thrombotic Complications in Patients with Immune-Mediated Hemolysis.J Clin Med. 2021 Apr 18;10(8):1764. doi: 10.3390/jcm10081764. J Clin Med. 2021. PMID: 33919638 Free PMC article. Review.
-
New insights into molecular pathogenesis of bone marrow failure in paroxysmal nocturnal hemoglobinuria.Int J Hematol. 2007 Jul;86(1):27-32. doi: 10.1532/IJH97.07029. Int J Hematol. 2007. PMID: 17675263 Review.
-
Regulation of the activity of platelet-bound C3 convertase of the alternative pathway of complement by platelet factor H.Proc Natl Acad Sci U S A. 1987 Aug;84(16):5873-7. doi: 10.1073/pnas.84.16.5873. Proc Natl Acad Sci U S A. 1987. PMID: 2956607 Free PMC article.
-
Management issues in paroxysmal nocturnal hemoglobinuria.Int J Hematol. 2003 Feb;77(2):125-32. doi: 10.1007/BF02983211. Int J Hematol. 2003. PMID: 12627847 Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous